UOC
BMRN icon

UBS O'Connor’s BioMarin Pharmaceuticals BMRN Stock Holding History

UBS O'Connor’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-5,258
Closed -$372K – 390
2025
Q1 		$372K Sell
5,258
-21,582
-80% -$1.45M 0.01% 231
2024
Q4 		$1.76M Buy
+26,840
New +$1.8M 0.04% 169
2016
Q3 		– Sell
-15,000
Closed -$1.17M – 424
2016
Q2 		$1.17M Buy
15,000
+2,938
+24% +$250K 0.03% 283
2016
Q1 		$995K Buy
+12,062
New +$981K 0.02% 320
2014
Q2 		– Sell
-17,500
Closed -$1.19M – 446
2014
Q1 		$1.19M Buy
+17,500
New +$1.29M 0.02% 312
2013
Q3 		– Sell
-47,000
Closed -$2.62M – 437
2013
Q2 		$2.62M Buy
+47,000
New +$2.93M 0.05% 301

Other funds holding BMRN

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return